Chromoblastomycosis: Report of a case from a non-endemic region

Hadj, Olfa El Amine El; Msakni, Issam; Lamine, Fehmi; Laabidi, Besma; Ammar, Bouzaiene

doi:10.7241/ourd.20171.27

Cited by 2 publications

(2 citation statements)

References 5 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 65 articles were selected between 1947 and 2018 describing 1,875 patients distributed between Madagascar (1,323 cases) [ 94 – 99 ], South Africa (156 cases) [ 100 – 106 ], Republic of the Congo and Democratic Republic of the Congo (121 cases) [ 107 – 115 ], Gabon (64 cases) [ 116 ], Zimbabwe (35 cases) [ 117 ], Uganda (34 cases) [ 118 ], Kenya (33 cases) [ 119 ], Cameroon (23 cases) [ 120 – 123 ], Morocco (18 cases) [ 124 – 132 ], Tanzania (17 cases) [ 133 , 134 ], Ethiopia (14 cases) [ 135 , 136 ], Angola (7 cases) [ 115 , 137 , 138 ], Nigeria (5 cases) [ 138 – 141 ], Tunisia (5 cases) [ 142 – 146 ], Reunion Island (5 cases) [ 147 – 149 ], Libya (4 cases) [ 150 – 153 ], Comoro Island (4 cases) [ 154 , 155 ], Sierra Leone (3 cases) [ 156 ], Senegal (2 cases) [ 157 , 158 ], Botswana (1 case) [ 159 ] and Djibouti (1 case) [ 160 ]. There are descriptions of CBM in Chad and the Ivory Coast.…”

Section: Resultsmentioning

confidence: 99%

The global burden of chromoblastomycosis

et al. 2021

View full text Add to dashboard Cite

Background Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination. Methods and findings In order to estimate the global burden of CBM, we retrospectively reviewed the published literature from 1914 to 2020. Over the 106-year period, a total of 7,740 patients with CBM were identified on all continents except Antarctica. Most of the cases were reported from South America (2,619 cases), followed by Africa (1,875 cases), Central America and Mexico (1,628 cases), Asia (1,390 cases), Oceania (168 cases), Europe (35 cases), and USA and Canada (25 cases). We described 4,022 (81.7%) male and 896 (18.3%) female patients, with the median age of 52.5 years. The average time between the onset of the first lesion and CBM diagnosis was 9.2 years (range between 1 month to 50 years). The main sites involved were the lower limbs (56.7%), followed by the upper limbs (19.9%), head and neck (2.9%), and trunk (2.4%). Itching and pain were reported by 21.5% and 11%, respectively. Malignant transformation was described in 22 cases. A total of 3,817 fungal isolates were cultured, being 3,089 (80.9%) Fonsecaea spp., 552 (14.5%) Cladophialophora spp., and 56 Phialophora spp. (1.5%). Conclusions and significance This review represents our current knowledge on the burden of CBM world-wide. The global incidence remains unclear and local epidemiological studies are required to improve these data, especially in Africa, Asia, and Latin America. The recognition of CBM as NTD emphasizes the need for public health efforts to promote support for all local governments interested in developing specific policies and actions for preventing, diagnosing and assisting patients.

show abstract

Section: Resultsmentioning

confidence: 99%

The global burden of chromoblastomycosis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In atypical variations of cutaneous tuberculosis, one needs to depend on examinations like histopathology, AFB examination, culture, or polymerase chain response (PCR) for confirmation [5]. Treatment and differentiating features of cutaneous tuberculosis was presented respectively in Table 1 and Table 2 [4,5,[6][7][8][9][10][11].…”

Section: Discussionmentioning

confidence: 99%

Tuberculosis verrucosa cutis masqerading as chromoblastomycosis – a case report

Manjumeena¹,

Sundaramoorthy²

2018

Our Dermatol Online

View full text Add to dashboard Cite

Chromoblastomycosis: Report of a case from a non-endemic region

Cited by 2 publications

References 5 publications

The global burden of chromoblastomycosis

The global burden of chromoblastomycosis

Tuberculosis verrucosa cutis masqerading as chromoblastomycosis – a case report

Contact Info

Product

Resources

About